(19)
(11) EP 4 543 924 A2

(12)

(88) Date of publication A3:
01.02.2024

(43) Date of publication:
30.04.2025 Bulletin 2025/18

(21) Application number: 23742567.3

(22) Date of filing: 21.06.2023
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61K 47/68(2017.01)
A61P 29/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2803; C07K 2317/21; C07K 2317/33; C07K 2317/92; A61P 29/00; A61K 47/6803; A61K 47/6849
(86) International application number:
PCT/US2023/068763
(87) International publication number:
WO 2023/250341 (28.12.2023 Gazette 2023/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 22.06.2022 US 202263354445 P

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, IN 46206-6288 (US)

(72) Inventors:
  • ANDREWS, Forest Hoyt
    Indianapolis, Indiana 46206-6288 (US)
  • CLAYTON, Joshua Ryan
    Indianapolis, Indiana 46206-6288 (US)
  • FELLOWS, Ross Edward
    Indianapolis, Indiana 46206-6288 (US)
  • MA, Bo
    Indianapolis, Indiana 46206-6288 (US)
  • TANG, Ying
    Indianapolis, Indiana 46206-6288 (US)
  • WURST, Jacqueline Mary
    Indianapolis, Indiana 46206-6288 (US)
  • YACHI, Pia Pauliina
    Indianapolis, Indiana 46206-6288 (US)
  • YANG, Chiao-Wen
    Indianapolis, Indiana 46206-6288 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) HUMAN CD33 ANTIBODIES AND GLUCOCORTICOID CONJUGATES